This is The Biggest Threat To Medifast, Inc. (MED), Independent Bank Corp. (INDB)

This target means that the stock has an upside potential to increase by 50.46% from the current trading price.

The company runs an ROE of roughly 51%, with financial analysts predicting that their earnings per share growth will be around 20% per annum for the next five year.

The first technical resistance point for Medifast, Inc. (NYSE:MED) will likely come at $148.6, marking a 0.71% premium to the current level.

INDB stock has performed well over the past 30 days, as it added 2.33% while its price climbed by 13.74% year-to-date (YTD).

In percentage terms, the aggregate Independent Bank Corp. shares held by institutional investors is 68.6%.

The next resistance point is at $87.34, representing nearly 8.44% premium to the current market price of Independent Bank Corp. (INDB).

Powered by Blogger.